Eli Lilly and Company Overview
Company: | Eli Lilly and Company |
---|---|
CEO: | Mr. David A. Ricks |
Symbol: | LLY |
Exchange: | NYSE |
Industry: | Drug Manufacturers - General |
Sector: | Healthcare |
About |
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company provides Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma; Cyramza for metastatic gastric cancer, gastro-esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, and hepatocellular carcinoma; Erbitux for colorectal cancers, and various head and neck cancers; Retevmo for metastatic NSCLC, medullary thyroid cancer, and thyroid cancer; Tyvyt for relapsed or refractory classic Hodgkin's lymph and non-squamous NSCLC; and Verzenio for HR+, HER2- metastatic breast cancer, node positive, and early breast cancer. It offers Olumiant for rheumatoid arthritis; and Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis. The company offers Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Emgality for migraine prevention and episodic cluster headache; and Zyprexa for schizophrenia, bipolar I disorder, and bipolar maintenance. Its Bamlanivimab and etesevimab, and Bebtelovimab for COVID-19; Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. The company has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals; AbCellera Biologics; Junshi Biosciences; Regor Therapeutics Group; Lycia Therapeutics; Kumquat Biosciences; Entos Pharmaceuticals; and Foghorn Therapeutics Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana. |
-
Ranking:
1 among 3046 companies
-
Address:
Lilly Corporate Center
-
City | State | Zip | Country:
Indianapolis | IN | 46285 | US
-
Phone:
317 276 2000
- Website:
Eli Lilly and Company (LLY)
- Stock Price
- Volume
- 1D
- 1W
- 1M
- 3M
- 6M
- YTD
- 1Y
- 2Y
- 5Y
- 10Y
- ALL
Income Statement
Assets & Liabilities | Cash Flow
Ratios
Profitability
Valuation
Eli Lilly and Company;LLY;https://bullfincher.io/logos/us/LLY.png;eli-lilly-and-company | 45042700000.00 |
---|---|
Johnson & Johnson;JNJ;https://bullfincher.io/logos/us/JNJ.png;johnson-johnson | 88821000000.00 |
AbbVie;ABBV;https://bullfincher.io/logos/us/ABBV.png;abbvie | 56334000000.00 |
Merck & Co.;MRK;https://bullfincher.io/logos/us/MRK.png;merck-co | 64168000000.00 |
Amgen;AMGN;https://bullfincher.io/logos/us/AMGN.png;amgen | 33424000000.00 |
Recently asked question
Some title 1
Lorem ipsum dolor sit amet consectetur. Ut enim massa vestibulum at odio iaculis. Orci euismod tristique turpis mauris ultrices senectus mattis volutpat dolor. Ultrices donec congue aenean sed. Amet ac consequat.
Some title 2
Lorem ipsum dolor sit amet consectetur. Ut enim massa vestibulum at odio iaculis. Orci euismod tristique turpis mauris ultrices senectus mattis volutpat dolor. Ultrices donec congue aenean sed. Amet ac consequat.
Lorem ipsum dolor sit amet consectetur. Ut enim massa vestibulum at odio iaculis. Orci euismod tristique turpis mauris ultrices senectus mattis volutpat dolor. Ultrices donec congue aenean sed. Amet ac consequat.
Some title 3
Lorem ipsum dolor sit amet consectetur. Ut enim massa vestibulum at odio iaculis. Orci euismod tristique turpis mauris ultrices senectus mattis volutpat dolor. Ultrices donec congue aenean sed. Amet ac consequat.
Lorem ipsum dolor sit amet consectetur. Ut enim massa vestibulum at odio iaculis. Orci euismod tristique turpis mauris ultrices senectus mattis volutpat dolor. Ultrices donec congue aenean sed. Amet ac consequat.
Some title 4
Lorem ipsum dolor sit amet consectetur. Ut enim massa vestibulum at odio iaculis. Orci euismod tristique turpis mauris ultrices senectus mattis volutpat dolor. Ultrices donec congue aenean sed. Amet ac consequat.
Some title 5
Lorem ipsum dolor sit amet consectetur. Ut enim massa vestibulum at odio iaculis. Orci euismod tristique turpis mauris ultrices senectus mattis volutpat dolor. Ultrices donec congue aenean sed. Amet ac consequat.
Some title 6
Lorem ipsum dolor sit amet consectetur. Ut enim massa vestibulum at odio iaculis. Orci euismod tristique turpis mauris ultrices senectus mattis volutpat dolor. Ultrices donec congue aenean sed. Amet ac consequat.